These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27695494)

  • 1. Socioeconomic determinants of prostate-specific antigen testing and estimation of the prevalence of undiagnosed prostate cancer in an elderly Polish population based on the PolSenior study.
    Prajsner A; Chudek J; Szybalska A; Piotrowicz K; Zejda J; Więcek A;
    Arch Med Sci; 2016 Oct; 12(5):1028-1035. PubMed ID: 27695494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of chronic kidney disease and its relation to socioeconomic conditions in an elderly Polish population: results from the national population-based study PolSenior.
    Chudek J; Wieczorowska-Tobis K; Zejda J; Broczek K; Skalska A; Zdrojewski T; Wiecek A
    Nephrol Dial Transplant; 2014 May; 29(5):1073-82. PubMed ID: 24092848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and socioeconomic predictors of diagnosed and undiagnosed diabetes in oldest-old and younger Caucasian seniors: results from the PolSenior study.
    Puzianowska-Kuźnicka M; Januszkiewicz-Caulier J; Kurylowicz A; Mossakowska M; Zdrojewski T; Szybalska A; Skalska A; Chudek J; Franek E
    Endokrynol Pol; 2021; 72(3):249-255. PubMed ID: 33749811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of prostate specific antigen testing for prostate cancer in elderly men.
    Dyche DJ; Ness J; West M; Allareddy V; Konety BR
    J Urol; 2006 Jun; 175(6):2078-82. PubMed ID: 16697807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of prostate cancer screening among health fair participants.
    Chiu BC; Anderson JR; Corbin D
    Public Health; 2005 Aug; 119(8):686-93. PubMed ID: 15949522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass screening of 12,027 elderly men for prostate carcinoma by measuring serum prostate specific antigen.
    Zhang HF; Wang HL; Xu N; Li SW; Ji GY; Li XM; Pan YZ; Zhang L; Zhao XJ; Gao HW
    Chin Med J (Engl); 2004 Jan; 117(1):67-70. PubMed ID: 14733776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Educational level and first-time PSA testing in general practice.
    Lerhmann-Lerche CS; Larsen SB; Andersen I; Thygesen LC; Kaae Andersen K; Duun-Henriksen AK; Johansen C; Røder MA; Brasso K; Dalton SO
    Scand J Urol; 2019 Oct; 53(5):275-281. PubMed ID: 31663414
    [No Abstract]   [Full Text] [Related]  

  • 9. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening.
    Assel M; Dahlin A; Ulmert D; Bergh A; Stattin P; Lilja H; Vickers AJ
    Eur Urol; 2018 Jun; 73(6):961-967. PubMed ID: 29066048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based study on the association between educational length, prostate-specific antigen testing and use of prostate biopsies.
    Nordström T; Bratt O; Örtegren J; Aly M; Adolfsson J; Grönberg H
    Scand J Urol; 2016; 50(2):104-9. PubMed ID: 26625178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographics and health-related factors of men receiving prostate-specific antigen screening in Utah.
    Merrill RM
    Prev Med; 2001 Dec; 33(6):646-52. PubMed ID: 11716662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in Australia.
    Ranasinghe WK; Kim SP; Lawrentschuk N; Sengupta S; Hounsome L; Barber J; Jones R; Davis P; Bolton D; Persad R
    BJU Int; 2014 Jan; 113(1):77-83. PubMed ID: 24053128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project.
    Pelzer AE; Tewari A; Bektic J; Berger AP; Frauscher F; Bartsch G; Horninger W
    Urology; 2005 Nov; 66(5):1029-33. PubMed ID: 16286118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, Despite no recommendations for PSA screening: results from a population-based study, 2003-2011.
    Nordström T; Aly M; Clements MS; Weibull CE; Adolfsson J; Grönberg H
    Eur Urol; 2013 Mar; 63(3):419-25. PubMed ID: 23083803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.
    Törnblom M; Norming U; Adolfsson J; Becker C; Abrahamsson PA; Lilja H; Gustafsson O
    Urology; 1999 May; 53(5):945-50. PubMed ID: 10223488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.
    Nordström T; Aly M; Eklund M; Egevad L; Grönberg H
    Eur Urol; 2014 Jun; 65(6):1184-90. PubMed ID: 23891454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer.
    Carter HB; Epstein JI; Chan DW; Fozard JL; Pearson JD
    JAMA; 1997 May; 277(18):1456-60. PubMed ID: 9145718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen testing of older men.
    Carter HB; Landis PK; Metter EJ; Fleisher LA; Pearson JD
    J Natl Cancer Inst; 1999 Oct; 91(20):1733-7. PubMed ID: 10528023
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.